
Stéphane Bancel
Amministratore Delegato presso MODERNA, INC.
Patrimonio netto: 553 M $ in data 30/11/2025
Profilo
Stphane Bancel è un uomo d'affari che è stato a capo di 5 diverse aziende. Attualmente occupa la posizione di Chief Executive Officer & Director presso Moderna, Inc., Chief Executive Officer & Director presso ModernaTX, Inc. (una filiale di Moderna, Inc.) e Amministratore Delegato di Moderna SpA. Bancel fa anche parte del consiglio di amministrazione di altre 5 società. Nella sua carriera passata Stphane Bancel ha occupato la posizione di Presidente presso BG Medicine, Inc, Executive Director-Global Manufacturing Strategy presso Eli Lilly & Co. Principal presso Eli Lilly & Co. Ltd. e amministratore delegato presso Eli Lilly Benelux SA (entrambe le società controllate da Eli Lilly & Co.) e amministratore delegato per bioMrieux SA. Stphane Bancel ha conseguito una laurea presso l'Università del Minnesota, una laurea presso la cole Centrale Paris e un MBA presso la Harvard Business School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
MODERNA, INC. 5,44% | 30/09/2025 | 21.269.463 ( 5,44% ) | 553 M $ | 30/11/2025 |
Ultime notizie su Stéphane Bancel
Posizioni attive di Stéphane Bancel
| Società | Posizione | Inizio |
|---|---|---|
| MODERNA, INC. | Amministratore Delegato | 01/03/2011 |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Investitore di Private Equity | 01/01/2013 |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. Develops therapeutics and novel medicines | Direttore/Membro del Consiglio | - |
Moderna SpA
Moderna SpA Wholesales food and non-food products | Amministratore Delegato | - |
Qiagen SRL
Qiagen SRL Provides molecular testing solutions | Direttore/Membro del Consiglio | - |
Indigo Ag, Inc.
Indigo Ag, Inc. Develops biological and digital technologies | Direttore/Membro del Consiglio | 02/08/2020 |
Museum of Science
Museum of Science Other Consumer ServicesConsumer Services Operates as a museum | Direttore/Membro del Consiglio | - |
QIAGEN GmbH
QIAGEN GmbH Miscellaneous Commercial ServicesCommercial Services Provides products for preanalytical sample preparation and molecular diagnostics solutions | Direttore/Membro del Consiglio | - |
ModernaTX, Inc.
ModernaTX, Inc. Develops messenger RNA therapeutics | Amministratore Delegato | - |
Precedenti posizioni note di Stéphane Bancel
| Società | Posizione | Fine |
|---|---|---|
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Stéphane Bancel
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 23 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Manufactures, wholesales and markets pharmaceutical products | |
QIAGEN NV
QIAGEN NV Medical SpecialtiesHealth Technology Manufactures and distributes sample and assay technology products for pre-analytical sample preparations | Health Technology |
Biotheranostics, Inc.
Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Discovers, develops and commercializes molecular diagnostic tests for cancer patients | Health Services |
BG Medicine, Inc.
BG Medicine, Inc. Medical SpecialtiesHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
Targanta Therapeutics Corp.
Targanta Therapeutics Corp. BiotechnologyHealth Technology Discovers and develops novel antibacterial pro drugs | Health Technology |
Tafkak, Inc.
Tafkak, Inc. Provides genome sequencing and analysis solutions | |
bioMérieux SA
bioMérieux SA Medical SpecialtiesHealth Technology Develops biotechnological products specializing in in-vitro diagnostics and infectious diseases | Health Technology |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
University of Minnesota
University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eli Lilly & Co. Ltd.
Eli Lilly & Co. Ltd. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical health care solutions | Health Technology |
QIAGEN GmbH
QIAGEN GmbH Miscellaneous Commercial ServicesCommercial Services Provides products for preanalytical sample preparation and molecular diagnostics solutions | Commercial Services |
École Centrale Paris
École Centrale Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Museum of Science
Museum of Science Other Consumer ServicesConsumer Services Operates as a museum | Consumer Services |
Eli Lilly Benelux SA
Eli Lilly Benelux SA Pharmaceuticals: MajorHealth Technology Engages in discovery and development of medicines | Health Technology |
ModernaTX, Inc.
ModernaTX, Inc. Develops messenger RNA therapeutics | |
Qiagen SRL
Qiagen SRL Provides molecular testing solutions | |
Syros Pharmaceuticals, Inc.
Syros Pharmaceuticals, Inc. Operates as a therapeutics company focusing on discovering and developing novel gene control therapies | |
Harvard Business School
Harvard Business School Functions as a College/University | |
Indigo Ag, Inc.
Indigo Ag, Inc. Develops biological and digital technologies | |
Moderna, Inc.
Moderna, Inc. Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | |
Moderna SpA
Moderna SpA Wholesales food and non-food products | |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. Develops therapeutics and novel medicines | |
Moderna Holding BV
Moderna Holding BV Functions as an investment holding company |
















